In another study involving melanoma and NSCLC patients, the amount of PD-L1 mRNA levels in plasma-derived exosomes was significantly lower in patients with treatment response and significantly higher in patients with disease progression (49). The gene discussed is CD274; the disease is non-small cell lung carcinoma.